Short description
ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer.
Description
ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer.
ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.
The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Carlos, California, United States, North America
Founded on
January 1, 1997
Exited on
February 8, 2012
Went public on
February 8, 2012
Stock symbol
CCXI
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh, Noaccess, Noaccessforu, Cannot Access, Uh Ohhhh, Absolutely Noaccess, Noaccessforu, Noaccess, Nopepepe
Sign in for full access
Founders
Thomas J. Schall